Target: Olivier Brandicourt, Chief Executive Officer of Sanofi
Goal: Tell a leading seller of insulin, which has dramatically increased the cost of its product, to lower the cost of this necessary drug.
For around 30 million Americans with diabetes, insulin is a necessary drug that allows them to live fairly normal lives. Without insulin, those with type-one diabetes could quickly fall into a coma that could end in death. The pharmaceutical industry should not be allowed to get away with greedily hiking up the cost of care that is necessary to so many Americans.
Since 2004, the manufacturing list price of insulin sold by Sanofi has gone up 400 percent. While other company’s price has gone up as well, Sanofi’s Lantus has seen the largest increase. Sanofi should not be rewarded for its seemingly insatiable appetite for money.
This is not the first time in the last year that the pharmaceutical industry’s greed has made headlines. The company Mylan came under fire after it increased the price of another life-saving drug, EpiPens, by 600 percent in just a few short years. Martin Shkreli became one of the most hated men in America after he increased the cost of another drug by 5,000 percent. The only way to put a stop to this kind of unjustifiable greed is by exposing it and speaking out against it.
Increasing these prices so drastically is effectively holding people hostage by withholding cures for cash. Demand that Sanofi make this life-saving drug more affordable to the public that depends on it by signing the petition below.
Dear Mr. Brandicourt,
The unjustifiable increase in the cost of life-saving insulin drugs is unacceptable. Since 2004, the manufacturing list price of insulin sold by Sanofi has gone up 400 percent. While other company’s prices have increased as well, Sanofi’s Lantus has seen the largest increase.
It is time to stop blaming other middle men for these cost increases. It is time the Sanofi takes responsibility for the corporate greed that endangers those that try to ration out the drug so they can afford it. Millions of Americans need this drug to live happy and healthy lives. If it is too expensive, how will they be able to access the care that they need?
Increasing these prices so drastically is effectively holding people hostage by withholding cures for cash. This not the way in which an ethical company operates. Healthcare should not be a luxury. We urge you to immediately reduce the cost of insulin and do what your industry is meant to do: save lives.
[Your Name Here]
Photo Credit: darkostojanovic